This startup develops diagnostic tools for detecting and managing various infections and inflammatory responses. Their tests help improve patient outcomes across conditions like COVID-19, pneumonia, TB, and autoimmune diseases by providing early detection and monitoring capabilities.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic methods for infections and inflammatory responses are often time-consuming, expensive, and not readily available at the point of need. Delays in diagnosis, particularly in cases like sepsis, can significantly increase the risk of mortality. The overuse of antibiotics due to the inability to rapidly rule out viral or non-bacterial infections contributes to antimicrobial resistance (AMR).
Solution
Septest is developing rapid, low-cost diagnostic tests for the detection and management of infections and inflammatory responses. These point-of-need tests are designed to integrate into existing healthcare settings, including hospitals, general practices, and community clinics. Septest's solutions aim to provide healthcare professionals with the information needed for timely and effective care, enabling early detection of infections, differentiation between bacterial and viral infections to combat AMR, and monitoring of inflammatory responses across a range of conditions. The tests are designed to be ultra-accessible, reducing barriers to diagnostic access, especially in low- and middle-income countries (LMICs).
Target Audience
The primary target audience includes healthcare professionals in hospital settings, general practice, and community clinics, as well as healthcare providers in low- and middle-income countries.
Features
- Rapid point-of-need diagnostic tests for infection and inflammation detection
- Tests designed for use in hospital settings, general practice, and community clinics
- Solutions to aid in the differentiation between bacterial and viral infections
- Tests designed to be low-cost and accessible for use in LMICs
- Designed to integrate seamlessly into existing healthcare settings
- Comprehensive diagnostic capabilities to improve patient outcomes across diverse conditions